bioRxiv·2 OctSotagliflozin Reprograms Hepatic Lipid Metabolism and Attenuates Atherosclerosis Beyond Empagliflozin in CKM MicePreprint: experiments in miceAtherosclerosisPaper
ADA Scientific Sessions 2026 Abstract·5 JunFasting Reveals Tissue-Specific Dysregulation of De Novo Lipogenesis in Diabetic MiceExperiments in animalsMechanismsPaper
ADA Scientific Sessions 2025 Abstract·13 JunThe Ketone Body β-hydroxybutyrate Mitigates Diabetic Kidney Disease through Metabolic ReprogrammingExperiments in animalsInterventionsPaper